Skip to content
★ Sign in to follow
SS

Shanghai Sanyou Medical Co., Ltd Stock: price and insider trades · China

三友医疗

CN·Mcap CN¥4.7BHealth Care

No insider purchase over the last 90 days. The latest, by 徐农, was filed 19 Mar 2024.

Shanghai Sanyou Medical Co., Ltd: what insiders have been doing

Shanghai Sanyou Medical Co., Ltd belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Between 4 November 2025 and 4 November 2026, 1 insider published 2 filings.

The flow runs one way only: 2 sales worth €5.4M, from 1 insider, and no purchase. 刘明岩 filed the largest sale, €4.3M, on 18 March 2026.

For context, the typical company on the same exchange (median of 517 companies) published 2 filings over the same period, against 2 filings here. Our records for Shanghai Sanyou Medical Co., Ltd go back to 2023, with 6 purchases and 11 sales on the open market in total.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
17
Thresholds
n/a
Buy Volume
€2M
6 ops. · all time
Sell Volume
€18M
11 ops. · all time

Who traded when

BuySale
刘明岩2 sales
David Fan1 sale
David Fan(范湘龙)1 sale

Since the insiders bought

  • Filed 19 Mar 2024 · 964 days ago · €147k
    +10.6%
    Entry CN¥13.72 · Close at T+365 CN¥15.17
  • Filed 27 Feb 2024 · 985 days ago · €87k
    +15.4%
    Entry CN¥13.32 · Close at T+365 CN¥15.37
  • Filed 27 Feb 2024 · 985 days ago · €71k
    +15.4%
    Entry CN¥13.32 · Close at T+365 CN¥15.37

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,745 of 26,912 companies
48.7
score / 100
Value
28
Quality
69
FCF yld0.8%
Earn yld1.3%
EV/EBITDA50.3x
ROE1.5%
Gross mgn75%
Net mgn12%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥12.89
Analyst consensus
·
Income statement
RevenueCN¥542.8M
Gross profitCN¥406.6M75% margin
EBITDACN¥94.8M17% margin
Net incomeCN¥63.1M9.6% margin
Valuation
PER (trailing)80.6x
P/Book2.2x
Beta-0.09
Balance sheet & cash
Market capCN¥4.7B
Total debtCN¥41.4M
Free Cash FlowCN¥39.1M
Debt / Equity2%
Profitability & ownership
ROE1.5%
ROA0.9%
% insiders39.4%
% institutions11.5%
Last declaration on 18 March 2026
Declarations17 total
  • ▼
    董事,核心技术人员Executives
    34M CNY15SSE
    1,847,708 shares78.7% of flowA股XSHGSSE:273000000261212800
  • ▼
    董事,核心技术人员Executives
    9M CNY9SSE
    469,386 shares21.3% of flowA股XSHGSSE:273000000244218800
  • ▼
    董事,高级管理人员Executives
    21M CNY15SSE
    1,400,000 shares82.0% of flowA股XSHGSSE:173000009288462400
  • ▼
    董事,高级管理人员Executives
    41M CNY15SSE
    2,600,000 shares100.0% of flowA股XSHGSSE:173000009113692770
  • ▲
    董事,高级管理人员Executives
    1M CNY24SSE
    69,300 shares19.4% of flowA股XSHGSSE:173000007404650660
    Canonical exit: 17 Jun 2024 (T+90)
  • ▲
    董事,高级管理人员Executives
    5M CNY30SSE
    289,886 shares80.6% of flowA股XSHGSSE:173000007402106270
    Canonical exit: 16 Jun 2024 (T+90)
  • ▲
    董事,核心技术人员Executives
    669,451 CNY19SSE
    40,377 shares1.4% of flowA股XSHGSSE:173000007349662460
    Canonical exit: 27 May 2024 (T+90)
  • ▲
    董事,高级管理人员Executives
    547,041 CNY19SSE
    33,000 shares2.3% of flowA股XSHGSSE:173000007349664350
    Canonical exit: 27 May 2024 (T+90)
  • ▲
    董事,核心技术人员Executives
    4M CNY20SSE
    260,778 shares9.0% of flowA股XSHGSSE:173000007346710800
    Canonical exit: 26 May 2024 (T+90)
  • ▲
    董事,高级管理人员Executives
    4M CNY21SSE
    219,922 shares15.6% of flowA股XSHGSSE:173000007346702900
    Canonical exit: 26 May 2024 (T+90)
  • ▼
    董事,高级管理人员,核心技术人员Executives
    10M CNY9SSE
    435,936 shares19.6% of flowA股XSHGSSE:173000006753872400
  • ▼
    董事,高级管理人员,核心技术人员Executives
    6M CNY8SSE
    260,023 shares11.8% of flowA股XSHGSSE:173000006749286050
  • ▼
    董事,高级管理人员,核心技术人员Executives
    6M CNY8SSE
    254,041 shares11.6% of flowA股XSHGSSE:173000006745501280
  • ▼
    董事,高级管理人员,核心技术人员Executives
    6M CNY8SSE
    252,120 shares12.0% of flowA股XSHGSSE:173000006739219940
  • ▼
    董事,高级管理人员,核心技术人员Executives
    11M CNY9SSE
    432,310 shares21.2% of flowA股XSHGSSE:173000006736740200
  • ▼
    董事,高级管理人员,核心技术人员Executives
    5M CNY8SSE
    197,344 shares10.0% of flowA股XSHGSSE:173000006736351680
  • ▼
    董事,高级管理人员,核心技术人员Executives
    2M CNY7SSE
    68,226 shares3.5% of flowA股XSHGSSE:173000006729948670

17 of 17 declarations

About Shanghai Sanyou Medical Co., Ltd

三友医疗 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and manufacturing of innovative medical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations